Publikationsserver der Universitätsbibliothek Marburg

Titel:Cyfra 21-1 as a serum tumor marker for follow up of patients with laryngeal and hypopharyngeal squamous cell carcinoma
Autor:Al-Shagahin, Hani
Weitere Beteiligte: Werner, Jochen (Prof.)
Veröffentlicht:2009
URI:https://archiv.ub.uni-marburg.de/diss/z2009/0796
DOI: https://doi.org/10.17192/z2009.0796
URN: urn:nbn:de:hebis:04-z2009-07963
DDC:610 Medizin, Gesundheit
Titel(trans.):Cyfra 21-1 als Serum Tumor Marker
Publikationsdatum:2010-01-26
Lizenz:https://rightsstatements.org/vocab/InC-NC/1.0/

Dokument

Schlagwörter:
Tumor, Markers

Summary:
AIM: To evaluate the importance and potential of Cyfra21-1 as a tumor marker (TM) for follow-up of patients with squamous cell carcinoma (SCC) in laryngeal and hypopharyngeal cancer. PATIENTS AND METHODS: Cyfra21-1 serum levels of 50 patients with laryngeal and hypopharyngeal SCC were evaluated by ECLIA assay. Statistical analysis was performed using Kruskal-Wallis and Jonckheere-Terpstra tests. RESULTS: There was no significant correlation between Cyfra21-1 levels at the time of initial diagnosis and the clinicopathological parameters. The clinical performance of Cyfra 21-1 as an individual tumor marker for follow-up of patients was good. This is shown by the area under the curve (0.873) of their receiver operating characteristic curves. The sensitivity and specificity of Cyfra 21-1 at a cut-off 3.3 ng/ml ere 61.1% and 96.9% respectively. CONCLUSION: Cyfra 21-1 is not suitable for early diagnosis of SCC of the larynx and hypopharynx. An abrupt increase of Cyfra 21-1 in serial measurements indicates impending disease progression in individual patients.

Zusammenfassung:
Untersuchung über die Bedeutung von Cyfra 21-1 als Serum Tumor Marker.


* Das Dokument ist im Internet frei zugänglich - Hinweise zu den Nutzungsrechten